218 related articles for article (PubMed ID: 15283001)
21. Transverse myelitis associated with restless legs syndrome and periodic movements of sleep responsive to an oral dopaminergic agent but not to intrathecal baclofen.
Brown LK; Heffner JE; Obbens EA
Sleep; 2000 Aug; 23(5):591-4. PubMed ID: 10947026
[TBL] [Abstract][Full Text] [Related]
22. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
23. The clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterization.
Hening W
Clin Neurophysiol; 2004 Sep; 115(9):1965-74. PubMed ID: 15294199
[TBL] [Abstract][Full Text] [Related]
24. Circadian rhythm of restless legs syndrome: relationship with biological markers.
Michaud M; Dumont M; Selmaoui B; Paquet J; Fantini ML; Montplaisir J
Ann Neurol; 2004 Mar; 55(3):372-80. PubMed ID: 14991815
[TBL] [Abstract][Full Text] [Related]
25. Appropriate use of dopamine agonists and levodopa in restless legs syndrome in an ambulatory care setting.
Molokwu OC
Ann Pharmacother; 2008 May; 42(5):627-32. PubMed ID: 18381842
[TBL] [Abstract][Full Text] [Related]
26. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial.
Trenkwalder C; Stiasny K; Pollmächer T; Wetter T; Schwarz J; Kohnen R; Kazenwadel J; Krüger HP; Ramm S; Künzel M
Sleep; 1995 Oct; 18(8):681-8. PubMed ID: 8560135
[TBL] [Abstract][Full Text] [Related]
27. Restless legs syndrome: evidence for nocturnal hypothalamic-pituitary-adrenal system activation.
Schilling C; Schredl M; Strobl P; Deuschle M
Mov Disord; 2010 Jun; 25(8):1047-52. PubMed ID: 20535825
[TBL] [Abstract][Full Text] [Related]
28. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
[TBL] [Abstract][Full Text] [Related]
29. [Restless legs syndrome: therapeutic possibilities in the medical practice].
Bachmann CG; Trenkwalder C
MMW Fortschr Med; 2005 May; 147 Spec No 2():44-7. PubMed ID: 15968872
[TBL] [Abstract][Full Text] [Related]
30. The treatment of the restless leg syndrome with or without periodic leg movements in sleep.
Montplaisir J; Lapierre O; Warnes H; Pelletier G
Sleep; 1992 Oct; 15(5):391-5. PubMed ID: 1360697
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome.
Kutukcu Y; Dogruer E; Yetkin S; Ozgen F; Vural O; Aydin H
Muscle Nerve; 2006 Jan; 33(1):133-7. PubMed ID: 16175624
[TBL] [Abstract][Full Text] [Related]
32. [Restless legs syndrome. Definition, cause and treatment].
Jennum PJ
Ugeskr Laeger; 2007 Sep; 169(38):3187-90. PubMed ID: 17910827
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics of Restless legs syndrome in patients with Parkinson's disease.
Nomura T; Inoue Y; Nakashima K
J Neurol Sci; 2006 Dec; 250(1-2):39-44. PubMed ID: 16899256
[TBL] [Abstract][Full Text] [Related]
34. Undiagnosed individuals with first-degree relatives with restless legs syndrome have increased periodic limb movements.
Birinyi PV; Allen RP; Hening W; Washburn T; Lesage S; Earley CJ
Sleep Med; 2006 Sep; 7(6):480-5. PubMed ID: 16934525
[TBL] [Abstract][Full Text] [Related]
35. Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome.
Hornyak M; Rupp A; Riemann D; Feige B; Berger M; Voderholzer U
Neurology; 2008 Apr; 70(18):1620-2. PubMed ID: 18443313
[TBL] [Abstract][Full Text] [Related]
36. Periodic limb movement disorder and restless legs syndrome in dialysis patients.
Rijsman RM; de Weerd AW; Stam CJ; Kerkhof GA; Rosman JB
Nephrology (Carlton); 2004 Dec; 9(6):353-61. PubMed ID: 15663636
[TBL] [Abstract][Full Text] [Related]
37. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
38. The severity range of restless legs syndrome (RLS) and augmentation in a prospective patient cohort: association with ferritin levels.
Frauscher B; Gschliesser V; Brandauer E; El-Demerdash E; Kaneider M; Rücker L; Poewe W; Högl B
Sleep Med; 2009 Jun; 10(6):611-5. PubMed ID: 19200780
[TBL] [Abstract][Full Text] [Related]
39. Some children with growing pains may actually have restless legs syndrome.
Rajaram SS; Walters AS; England SJ; Mehta D; Nizam F
Sleep; 2004 Jun; 27(4):767-73. PubMed ID: 15283013
[TBL] [Abstract][Full Text] [Related]
40. Clinical symptomatology and treatment of restless legs syndrome and periodic limb movement disorder.
Stiasny K; Oertel WH; Trenkwalder C
Sleep Med Rev; 2002 Aug; 6(4):253-65. PubMed ID: 12531131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
